Illinois Depo Provera Brain Tumor Lawsuit in 2025

Award Logos
Collen Clark Published by Collen Clark

Free Confidential Illinois Depo Provera Brain Tumor Lawsuit Review

If you or a loved one has developed a brain tumor after using Depo-Provera, you may be entitled to pursue compensation.

At Schmidt & Clark, LLP, we are dedicated to helping individuals who have suffered due to these serious health complications. Our experienced legal team is here to guide you through the process and fight for the compensation you deserve.

Contact Schmidt & Clark, LLP today for a free, no-obligation consultation.

Start Your Free Case Review Now

Illinois Depo Provera Brain Tumor Lawsuit Overview

Depo-Provera, an injectable contraceptive, has faced scrutiny for its potential link to brain tumors, leading to numerous lawsuits against Pfizer, the manufacturer.

Women who developed brain tumors after using Depo-Provera are seeking justice, claiming Pfizer failed to warn about the significant risks.

These lawsuits allege that Pfizer’s inadequate warnings about the potential for developing brain tumors, particularly meningiomas, after prolonged use of Depo-Provera constitute negligence.

Latest Depo-Provera Lawsuit Updates

  • April 3, 2025 – Multiple lawsuits have been consolidated in federal court as plaintiffs continue to come forward with brain tumor diagnoses following long-term Depo-Provera use. Court documents reveal that over 500 cases have been filed nationwide.
  • January 15, 2025 – A preliminary settlement discussion has begun in several key cases, with Pfizer representatives meeting with plaintiff attorneys to discuss potential resolution frameworks.
  • November 10, 2024 – New research published in the Journal of Neurology strengthened the connection between prolonged Depo-Provera use and increased risk of meningiomas, particularly in women who used the contraceptive for more than 5 years.
  • September 22, 2024 – The FDA announced an updated safety review of Depo-Provera, specifically examining the potential brain tumor risk after receiving hundreds of adverse event reports.
  • July 8, 2024 – The first bellwether trial date was set for March 2025 in Illinois federal court, representing a significant advancement in the litigation process.

FDA Reports and Statistics

Research published in the British Medical Journal highlights that long-term use of injectable medroxyprogesterone acetate, the active ingredient in Depo-Provera, is associated with a significant rise in brain tumors [1].

The risk of developing meningiomas increases substantially with the duration of Depo-Provera use, significantly beyond one year among women.

Studies indicate that women using Depo-Provera for over 12 months have a 5.6-fold increased risk of developing meningiomas.

This dramatic increase in risk underscores the importance of being informed about the potential dangers of prolonged Depo-Provera use.

Depo-Provera Injuries & Side Effects

Depo-Provera use has been linked to several serious side effects, particularly concerning brain health.

  • Meningioma: The most common primary tumor of the central nervous system, developing in the protective membranes of the brain and spinal cord.
  • Neurological Damage: Including vision changes, persistent headaches, and memory issues.
  • Seizures: Sudden electrical disturbances in the brain that can be life-threatening.
  • Physical Impairment: Including limb weakness and difficulty speaking as the tumor grows.

Do You Qualify for a Depo-Provera Lawsuit?

You may qualify for a Depo-Provera lawsuit if:

  • You have used Depo-Provera, Depo-SubQ Provera, or a generic version for birth control or to treat endometriosis
  • You have a confirmed diagnosis of meningioma after using the contraceptive
  • You can provide medical documentation linking your diagnosis to Depo-Provera use
  • Your condition required medical treatment or hospitalization

Evidence Required for a Depo-Provera Lawsuit

Supporting a Depo-Provera brain tumor lawsuit requires solid evidence, including:

  • Medical records that prove the diagnosis of a brain tumor
  • Prescription details that link Depo-Provera’s use to the diagnosis
  • Documentation of the duration and dosage of Depo-Provera used
  • Medical expert testimony connecting Depo-Provera to the development of meningioma
  • Any communication with healthcare providers regarding the risks of Depo-Provera

Damages You Can Recover

Filing a Depo-Provera lawsuit can help cover:

  • Medical expenses (past and future)
  • Lost wages and diminished earning capacity
  • Pain and suffering
  • Emotional distress
  • Reduced quality of life
  • Funeral costs (in wrongful death cases)

Depo Provera Recall Information

As of April 2025, Pfizer has not issued a full recall of Depo-Provera despite mounting legal pressure and evidence suggesting a connection to brain tumors.

However, the FDA has required updated warning labels regarding the potential risk of meningiomas with long-term use.

In France and several European countries, regulatory agencies have restricted Depo-Provera’s use due to the potential brain tumor risk, requiring additional patient counseling and monitoring for any woman using the contraceptive for more than two consecutive years.

Statute of Limitations for Depo Provera Lawsuits

The statute of limitations for filing a Depo-Provera lawsuit varies by state but typically ranges from 1-6 years from the date of injury discovery. Important state-specific timeframes include:

  • Illinois: 2 years from date of discovery
  • California: 2 years from date of discovery
  • New York: 3 years from date of discovery
  • Texas: 2 years from date of discovery
  • Florida: 4 years from date of discovery

These timeframes underscore the importance of contacting an attorney promptly after receiving a diagnosis potentially linked to Depo-Provera use.

Frequently Asked Questions

1. What is Depo-Provera and how does it work?

Depo-Provera is a widely used birth control medication administered as injections every three months. It uses a synthetic hormone called medroxyprogesterone acetate to prevent ovulation, thicken cervical mucus to block sperm transport, and thin the uterine lining. When used correctly, it’s over 99% effective in preventing pregnancy and is also prescribed for managing endometriosis and reducing uterine cancer risk [2].

2. What is the link between Depo-Provera and brain tumors?

Recent studies have established a connection between Depo-Provera and an increased risk of meningiomas. Research published in the British Medical Journal shows that long-term use of injectable medroxyprogesterone acetate significantly increases the risk of brain tumors, with women using it for over 12 months having a 5.6-fold higher risk of developing meningiomas.

3. What are the symptoms of meningioma?

Common symptoms of meningioma include changes in vision, persistent headaches, hearing loss, memory issues, and seizures. As the tumor grows, some individuals may experience limb weakness and difficulty speaking. Seeking medical attention is crucial if there is a sudden onset of seizures or abrupt changes in vision or memory [3].

4. How do I know if I qualify for a Depo-Provera lawsuit in Illinois?

You may qualify if you’ve used Depo-Provera, Depo-SubQ Provera, or a generic version and have a confirmed diagnosis of meningioma afterward. Consulting with a product liability attorney can help determine the validity of your claim and guide you through seeking compensation.

5. What is the average settlement amount for Depo-Provera brain tumor cases?

Settlement values for successful Depo-Provera brain tumor cases range from $275,000 to $500,000, reflecting the severity of health challenges and their impact on quality of life. These amounts can vary based on individual circumstances, medical expenses, and other factors.

6. What steps should I take to file a Depo-Provera lawsuit?

To file a lawsuit, collect all medical records and documentation of Depo-Provera use, consult with a specialized attorney, ensure you file before the statute of limitations expires, and gather all relevant evidence including medical bills and expert testimony to build a strong case.

7. Is there a cost to consult with a Depo-Provera lawsuit attorney?

Most firms handling Depo-Provera cases, including Schmidt & Clark, LLP, offer free consultations and operate on a contingency fee basis, meaning you only pay if they win your case. This arrangement makes legal representation accessible to those who might otherwise be unable to afford it.

8. How long does a Depo-Provera lawsuit typically take to resolve?

The timeline for resolution varies based on case complexity, evidence strength, and whether a settlement is reached or the case goes to trial. Currently, Depo-Provera litigation is in its early stages, with no verdicts or settlements yet established to provide a clear timeline reference.

Get A Free Depo-Provera Lawsuit Evaluation With Our Lawyers

Time is limited to pursue legal action against Pfizer for Depo-Provera-related brain tumors. With only 2-4 years from the date of discovery to file in most states, acting promptly is crucial to preserving your legal rights.

Schmidt & Clark, LLP offers:

  • Free, confidential consultations to evaluate your case
  • No upfront costs or attorney fees
  • Payment only if we win compensation for you
  • Nationwide representation with specialized expertise in pharmaceutical litigation

Don’t navigate this complex legal process alone. Our experienced attorneys have a strong track record in pharmaceutical injury cases and are committed to fighting for the compensation you deserve.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

References:

  1. https://www.bmj.com/content/384/bmj-2023-078078
  2. https://www.mayoclinic.org/tests-procedures/depo-provera/about/pac-20392204
  3. https://www.pennmedicine.org/for-patients-and-visitors/patient-information/conditions-treated-a-to-z/meningioma

Get a Free Case Review

You may be entitled to financial compensation.
  • This field is for validation purposes and should be left unchanged.
Secure Submission